These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9213829)

  • 1. [Effectiveness and tolerability of heparan sulfate in the treatment of superficial thrombophlebitis. Controlled clinical study vs sulodexide].
    Messa G; La Placa G; Puccetti L; Di Perri T
    Minerva Cardioangiol; 1997 Apr; 45(4):147-53. PubMed ID: 9213829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Heparan sulfate in the therapy of postphlebitic syndrome. Evaluation of the efficacy and tolerability as compared to mesoglycan].
    Giorgetti PL; Marenghi MC; Bianciardi P
    Minerva Cardioangiol; 1997 Jun; 45(6):279-84. PubMed ID: 9432569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of anti-thrombophilic properties of heparan sulfate in venous vascular pathology. A controlled clinical study versus active reference].
    Ganassin L; Sogaro F; Galeazzi E
    Minerva Cardioangiol; 1991; 39(7-8):275-83. PubMed ID: 1780078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of short-term sulodexide treatment on peripheral vascular disease clinical manifestations.
    Caramelli L; Mirchioni R; Carini A
    Riv Eur Sci Med Farmacol; 1988 Feb; 10(1):55-8. PubMed ID: 3079198
    [No Abstract]   [Full Text] [Related]  

  • 5. [Heparan sulphate in association with indobufen in the treatment of chronic peripheral obliterative arteriopathy of the lower extremities. Controlled clinical trial].
    Rossini A; Tascino C; Costa F
    Minerva Cardioangiol; 1998 Nov; 46(11):457-69. PubMed ID: 10207294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Heparan sulfate: efficacy and safety in patients with chronic venous insufficiency].
    Agrati AM; De Bartolo G; Palmieri G
    Minerva Cardioangiol; 1991 Oct; 39(10):395-400. PubMed ID: 1839430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of a natural mucopolysaccharide-fibrinolytic complex on venous thrombosis and on the clearing factor].
    Pirani R; Pozzar C; De Lorenzi E
    Clin Ter; 1982 Mar; 100(6):575-96. PubMed ID: 6211330
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
    Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sulodexide in the treatment of venous thrombosis].
    Penka M
    Vnitr Lek; 1995 Mar; 41(3):169-71. PubMed ID: 7762172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulodexide versus calcium heparin in the medium-term treatment of deep vein thrombosis of the lower limbs.
    Pinto A; Corrao S; Galati D; Arnone S; Licata A; Parrinello G; Maniscalchi T; Licata G
    Angiology; 1997 Sep; 48(9):805-11. PubMed ID: 9313630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulodexide: a renewed interest in this glycosaminoglycan.
    Lauver DA; Lucchesi BR
    Cardiovasc Drug Rev; 2006; 24(3-4):214-26. PubMed ID: 17214598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulodexide in the treatment of chronic venous disease.
    Andreozzi GM
    Am J Cardiovasc Drugs; 2012 Apr; 12(2):73-81. PubMed ID: 22329592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of a minor fibrinolytic drug (mesoglycan) in phlebitis].
    Scondotto G; De Fabritiis A; Guastarobba A; Amato AC; Filippini M
    Minerva Med; 1984 Jul; 75(28-29):1733-8. PubMed ID: 6236381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One year course of oral sulodexide in the management of diabetic nephropathy.
    Achour A; Kacem M; Dibej K; Skhiri H; Bouraoui S; El May M
    J Nephrol; 2005; 18(5):568-74. PubMed ID: 16299683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Coagulation tests in septic surgical patients].
    Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
    Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective double-arm study of fibrinolysis in surgical patients.
    Kosir MA; Schmittinger L; Barno-Winarski L; Duddella P; Pone M; Perales A; Lange P; Brish LK; McGee K; Beleski K; Pawlak J; Mammen E; Sajahan NP; Kozol RA
    J Surg Res; 1998 Jan; 74(1):96-101. PubMed ID: 9536981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study of the efficacy of mesoglycan in the treatment of venous diseases of the legs].
    Vercelloni M; Cogo R; Furcolo F; Monzani G; Casali W; Di Franco G
    Clin Ter; 1985 Nov; 115(3):173-6. PubMed ID: 2935355
    [No Abstract]   [Full Text] [Related]  

  • 18. Heparan sulfate in the treatment of intermittent claudication: results of a randomized, double-blind, placebo-controlled multicenter trial.
    Messa GL; Gelso E
    Drugs Exp Clin Res; 2002; 28(1):37-48. PubMed ID: 12073766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemorheology and tissue oxygenation in hypertensives with lipoidoproteinosis and peripheral occlusive arterial disease (POAD) treated with sulodexide and pravastatine and evaluated with laser assisted optical rotational red cell analyzer (LORCA) and transcutaneous oxymetry.
    Cicco G; Stingi GD; Vicenti P; Tarallo MS; Pirrelli A
    Minerva Cardioangiol; 1999 Oct; 47(10):351-9. PubMed ID: 10670256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised, double blind, multicentre, placebo controlled study of sulodexide in the treatment of venous leg ulcers.
    Coccheri S; Scondotto G; Agnelli G; Aloisi D; Palazzini E; Zamboni V;
    Thromb Haemost; 2002 Jun; 87(6):947-52. PubMed ID: 12083500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.